Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450190
Status:
COMPLETED
Last Update Posted:
2018-07-23
First Post:
2007-03-21
Brief Title:
Saizen E-Device User Trial
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Study Overview
Official Title:
User Trial on the Use in Common Practice of a New Electronic Auto-injector of Saizen the E-Device Electronic Device in Children Treated by Recombinant Human Growth Hormone Over a Period of 2 Months
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate the E-Device performances and handling on the use in common practice by collecting the impressions of patients nurses and the investigator on the graphic interface the instructions manual the E-Device training and the material itself
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None